Approval · Notice of Compliance 747 · 2002
PMS-PIMOZIDE: Notice of Compliance 747
Issued September 3, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 747
- Date
- September 3, 2002
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in formulation for 2mg and 4mg tablets
- Therapeutic class
- Antipsychotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-PIMOZIDE | Not yet assigned | — |